サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1472372

吸入カプセル市場：タイプ別、用途別：世界の機会分析と産業予測、2023年～2032年

Inhalation Capsules Market By Type (Gelatin Capsules, Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日
ページ情報
英文 320 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
吸入カプセル市場：タイプ別、用途別：世界の機会分析と産業予測、2023年～2032年
出版日: 2024年03月01日
発行: Allied Market Research
ページ情報: 英文 320 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の吸入カプセル市場は、2022年の8億2,240万米ドルから2023年から2032年までのCAGR 6.4％で成長し、2032年には14億6,490万米ドルに達すると予測されています。

Inhalation Capsules Market-IMG1

吸入カプセルは、薬剤を肺に直接送達する能力があるため、呼吸器疾患の迅速かつ集中的な治療が可能です。このカスタマイズされた投与戦略により、治療効果を高めながら全身的な副作用を最小限に抑えることができます。通常、カプセルは、ドライパウダー吸入器（DPI）や定量吸入器（MDI）のような特殊な吸入装置とともに使用されるように設計されています。製薬業界が薬物療法を提供するためのより効果的な新しい方法を模索し続ける中、吸入カプセルは実行可能な選択肢として台頭してきています。

市場成長を促進すると予測される主な理由の一つは、吸入によって達成される薬物送達の卓越した有効性です。呼吸器系は循環に直接かつ効率的な経路を提供するため、投薬活動を即座に開始することができます。このことは、迅速な救済が必要とされる、重篤な悪化を特徴とする疾患の治療には特に重要です。肺は薬物吸収のための巨大な表面積を提供し、薄い肺胞膜によって治療用化学物質が迅速に血流に到達します。その結果、吸入カプセルは従来の経口投与よりも迅速かつ直接的な薬理学的反応を示し、患者はより迅速な緩和とより良好な全体的転帰を経験することができます。作用の発現が速いため、吸入カプセルの有効性が高まる。

医薬品、特に吸入カプセルを監督する厳しい規制の枠組みは、市場の収益成長を妨げると予想される主な要因の1つです。規制当局は、医薬品の安全性、有効性、高品質を確保するために厳格な基準とプロセスを用いています。製造業者は適正製造基準（GMP）に準拠する必要があり、製造工程の各段階を完全に管理する必要があります。これらの規制を遵守するためには、技術、設備、人材育成に多大な投資を行う必要があり、製造プロセス全体の複雑さを増しています。吸入カプセルの複雑な設計と内容物は、その複雑さを助長しています。これらのカプセルは通常、ポリマーのような特殊な材料を含み、厳しい安定性、適合性、生体適合性の基準を満たさなければならないです。

吸入カプセルは、製薬会社にとって、現在の薬剤を再製剤化したり、呼吸経路でうまく投与できる新規の化学物質を導入したりするまたとないチャンスとなります。吸入カプセルは、より早い作用開始、より少ない全身性副作用、より良い患者コンプライアンスなどの利点を提供することにより、医薬品開発パイプラインを活性化する可能性を秘めています。製薬セクターは、呼吸器疾患、全身疾患、さらには予防接種を含む様々な治療領域向けに吸入可能な製剤を製造するための研究開発に投資することで、こうした展望を生かすことができると思われます。これらすべての要因が、予測期間中に吸入カプセル市場にいくつかの成長機会を生み出すと予想されます。

本レポートで紹介する主要企業は、Capsugel、Qualicaps、ACG Worldwide、Cipla、Novartis、AstraZeneca plc、Chiesi Farmaceutici S.p.A.、Elpen S.A.、Vectura Group Plc、Boehringer Ingelheim GmbHなどです。市場参入企業は、製品ポートフォリオの多様化やM&Aなどの戦略を駆使して、競争の激しい市場で優位なポジションを獲得しようと努力を続けています。

利害関係者にとっての主なメリット

  • 当レポートは、2022年から2032年までの吸入カプセル市場分析の市場セグメント、現在の動向、推定・動向、力学の定量分析を提供し、吸入カプセル市場の有力な機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの効力を強調します。
  • 吸入カプセルの市場セグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションの明確な理解を提供します。
  • 本レポートには、地域および世界の吸入カプセル市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 製造能力
  • 製品ライフサイクル
  • 市場参入戦略
  • 製品／セグメント別の市場セグメンテーション
  • 主要企業の新製品開発/製品マトリックス
  • 規制ガイドライン
  • クライアントの関心に特化した追加企業プロファイル
  • クリスクロスセグメント分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）
  • 世界/地域/国別レベルでのプレーヤーの市場シェア分析
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 平均販売価格
  • 市場シェア分析
  • ブランドシェア分析
  • 貿易データ分析
  • 製品消費
  • バリューチェーン分析
  • 主要規制分析
  • 特許情勢
  • 規制ガイドライン
  • 償還シナリオ

第4章 吸入カプセル市場：タイプ別

  • 概要
  • ゼラチンカプセル
  • ヒプロメロースカプセル

第5章 吸入カプセル市場：用途別

  • 概要
  • 喘息治療
  • COPD管理
  • その他

第6章 吸入カプセル市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イルタイ
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第8章 企業プロファイル

  • Capsugel
  • Qualicaps
  • ACG Worldwide
  • Cipla
  • Novartis
  • AstraZeneca Plc
  • CHIESI Farmaceutici S.p.A.
  • Elpen S.A.
  • Vectura Group plc.
  • Boehringer Ingelheim GmbH
図表

LIST OF TABLES

  • TABLE 01. GLOBAL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 05. INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. INHALATION CAPSULES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. INHALATION CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. NORTH AMERICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 12. U.S. INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. CANADA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. GERMANY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. UK INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. UK INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. ILTAY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. ILTAY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. REST OF EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. CHINA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. CHINA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. JAPAN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. JAPAN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. INDIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. INDIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. SOUTH KOREA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. SOUTH KOREA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. AUSTRALIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. AUSTRALIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. LAMEA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 51. BRAZIL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. SAUDI ARABIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SAUDI ARABIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. SOUTH AFRICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SOUTH AFRICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. REST OF LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CAPSUGEL: KEY EXECUTIVES
  • TABLE 62. CAPSUGEL: COMPANY SNAPSHOT
  • TABLE 63. QUALICAPS: KEY EXECUTIVES
  • TABLE 64. QUALICAPS: COMPANY SNAPSHOT
  • TABLE 65. ACG WORLDWIDE: KEY EXECUTIVES
  • TABLE 66. ACG WORLDWIDE: COMPANY SNAPSHOT
  • TABLE 67. CIPLA: KEY EXECUTIVES
  • TABLE 68. CIPLA: COMPANY SNAPSHOT
  • TABLE 69. NOVARTIS: KEY EXECUTIVES
  • TABLE 70. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 71. ASTRAZENECA PLC: KEY EXECUTIVES
  • TABLE 72. ASTRAZENECA PLC: COMPANY SNAPSHOT
  • TABLE 73. CHIESI FARMACEUTICI S.P.A.: KEY EXECUTIVES
  • TABLE 74. CHIESI FARMACEUTICI S.P.A.: COMPANY SNAPSHOT
  • TABLE 75. ELPEN S.A.: KEY EXECUTIVES
  • TABLE 76. ELPEN S.A.: COMPANY SNAPSHOT
  • TABLE 77. VECTURA GROUP PLC.: KEY EXECUTIVES
  • TABLE 78. VECTURA GROUP PLC.: COMPANY SNAPSHOT
  • TABLE 79. BOEHRINGER INGELHEIM GMBH: KEY EXECUTIVES
  • TABLE 80. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. INHALATION CAPSULES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF INHALATION CAPSULES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN INHALATION CAPSULES MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN INHALATION CAPSULES MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL INHALATION CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: INHALATION CAPSULES MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. INHALATION CAPSULES MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. INHALATION CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. INHALATION CAPSULES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 22. U.S. INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. CANADA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. MEXICO INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. GERMANY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. FRANCE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. ILTAY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. REST OF EUROPE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CHINA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. JAPAN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. INDIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. AUSTRALIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. BRAZIL INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SAUDI ARABIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SOUTH AFRICA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF LAMEA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: INHALATION CAPSULES MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2022
目次
Product Code: A296225

The global inhalation capsule market is anticipated to reach $1,464.9 million by 2032, growing from $822.4 million in 2022 at a CAGR of 6.4 % from 2023 to 2032.

Inhalation Capsules Market - IMG1

Inhalation capsules' capacity to deliver medications directly to the lungs allows for quick and concentrated treatment of respiratory illnesses. This customized administration strategy minimizes systemic side effects while boosting therapeutic efficacy. Typically, capsules are designed to be used with specialized inhalation devices such as dry powder inhalers (DPIs) or metered-dose inhalers (MDIs). As the pharmaceutical industry continues to look for new and more effective ways to provide medication, inhalation capsules are emerging as a viable option.

One of the key reasons projected to drive the market growth is the exceptional efficacy of medicine delivery achieved by inhalation. The respiratory system offers a direct and efficient route to the circulation, allowing medication activity to begin immediately. This is particularly crucial for treating diseases characterized by severe aggravations, as quick relief is required. The lungs provide a huge surface area for drug absorption, and the thin alveolar membranes allow therapeutic chemicals to reach the bloodstream rapidly. As a result, inhalation capsules give a more rapid and direct pharmacological response than traditional oral delivery, allowing patients to experience quicker relief and better overall outcomes. The rapid onset of action increases the efficacy of inhalation capsules.

Stringent regulatory framework that oversees pharmaceutical products, particularly inhalation capsules is one of the major factors anticipated to hamper the market revenue growth. Regulatory authorities use strict criteria and processes to ensure that pharmaceuticals are safe, effective, and of high quality. Manufacturers need to stick to Good Manufacturing Practices (GMP), which requires maintaining complete control over every stage of the production process. Compliance with these regulations necessitates substantial investment in technology, equipment, and personnel training, which adds to the overall complexity of the production process. The intricate design and content of inhalation capsules contribute to their complexity. These capsules usually include specialized materials, such as polymers, that must meet stringent stability, compatibility, and biocompatibility criteria.

Inhalation capsules provide pharmaceutical firms a unique chance to reformulate current medications or introduce novel chemicals that can be successfully given via the respiratory route. Inhalation capsule has the potential to revitalize drug development pipelines by providing benefits such as a faster start of action, less systemic adverse effects, and better patient compliance. The pharmaceutical sector may capitalize on these prospects by investing in R&D to produce inhalable formulations for a variety of therapeutic areas, including respiratory disorders, systemic ailments, and even vaccinations. All these factors are anticipated to create several growth opportunities in the inhalation capsules market during the forecast period.

The key players profiled in this report include Capsugel, Qualicaps, ACG Worldwide, Cipla, Novartis, AstraZeneca plc, Chiesi Farmaceutici S.p.A., Elpen S.A., Vectura Group Plc, and Boehringer Ingelheim GmbH. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as diversification of product portfolios & mergers and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inhalation capsules market analysis from 2022 to 2032 to identify the prevailing inhalation capsules market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the inhalation capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global inhalation capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Manufacturing Capacity
  • Product Life Cycles
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Gelatin Capsules
  • Hypromellose Capsules

By Application

  • Asthma Treatment
  • COPD Management
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Iltay
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Capsugel
    • Qualicaps
    • ACG Worldwide
    • Cipla
    • Novartis
    • AstraZeneca Plc
    • CHIESI Farmaceutici S.p.A.
    • Elpen S.A.
    • Vectura Group plc.
    • Boehringer Ingelheim GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Reimbursement Scenario

CHAPTER 4: INHALATION CAPSULES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Gelatin Capsules
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Hypromellose Capsules
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: INHALATION CAPSULES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Asthma Treatment
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. COPD Management
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: INHALATION CAPSULES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Iltay
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. United Arab Emirates
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by Application
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Market size and forecast, by Type
      • 6.5.4.5.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Capsugel
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
  • 8.2. Qualicaps
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
  • 8.3. ACG Worldwide
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
  • 8.4. Cipla
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
  • 8.5. Novartis
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
  • 8.6. AstraZeneca Plc
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
  • 8.7. CHIESI Farmaceutici S.p.A.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
  • 8.8. Elpen S.A.
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
  • 8.9. Vectura Group plc.
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
  • 8.10. Boehringer Ingelheim GmbH
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot